middle.news
AVITA Medical Eyes 19% Growth in 2026 After Solid Q4 Performance
9:50am on Friday 13th of February, 2026 AEDT
•
Healthcare
Read Story
AVITA Medical Eyes 19% Growth in 2026 After Solid Q4 Performance
9:50am on Friday 13th of February, 2026 AEDT
Key Points
Q4 2025 revenue growth sustained with 81.2% gross margin
Full-year 2025 revenue reached US$71.6 million, up 11% year-on-year
2026 revenue guidance set between US$80 million and US$85 million
New $60 million debt facility refinances existing debt on better terms
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
AVH
OPEN ARTICLE